Cti Biopharma Corp (CTIC) Return on Investment ROI from the first quarter of 2023 to first quarter of 2022 and for the year 2023, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cti Biopharma Corp   (NASDAQ: CTIC)


Cti Biopharma's ROI from its first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cti Biopharma's ROI in the first quarter of 2023?
Cti Biopharma Corp recorded a cumulative net loss of $-69 million during 12 months ending in the first quarter of 2023, resulting in a negative return on investment (ROI) of -96.41%.

Within the Healthcare sector 858 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2023 quarter, so far to 4676, from total ROI ranking in the fourth quarter of 2022 at 4905.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Investment Change TTM 106.85 % 106.38 % 40.05 % 1.79 % -22.7 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 44 45 94 105 33
Return On Investment (TTM) -96.41 % -134.9 % -189.79 % -265.6 % -339.33 %
CTIC's Overall Ranking # 4676 # 4905 # 0 # 0 # 0
Seq. Investment Change TTM 4.19 % 16.48 % 30.13 % 30.99 % 3.95 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -69 -93 -112 -121 -118

CTIC Company Profile >> Back to CTIC Roi Comparisons >> See Annual CTIC Return On Investment



Return On Investment CTIC's Ranking
Within: No.
Industry # 405
Sector # 859
Overall # 4676

Return On Investment Statistics
High Average Low
-41.02 %
-309.6 %
-2155.2 %
(Dec 31 2018)   (Sep. 30, 2015)







Financial Statements
Cti Biopharma's I. Quarter Investments $ 44 Millions CTIC's Balance sheet
Cti Biopharma's I. Quarter Income $ -13 Millions Quarterly CTIC's Income Statement
CTIC's Income by Division See CTIC's Income by Division


CTIC Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 45 6 41 22 61
Y / Y Investment Growth 674.53 % -85.96 % 87 % -63.89 % 104.05 %
Net Income in Millions -93 -98 -52 -40 -29
Y / Y Net Income Growth - - - - -
Annual Return On Investment -207.61 % -1693.03 % -127.3 % -181.64 % -48.1 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CTIC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CTIC's Competitors
Subscribers only: Roi for Cti Biopharma's Suppliers
Subscribers only: Return On Investment for CTIC's Customers

Other Ratios
CTIC's Roa CTIC's Inventory Turnover Ratio CTIC's Growth Rates CTIC's Dividend Statistics
CTIC's Profitability Ratios CTIC's Asset Turnover Ratio CTIC's Dividend Growth
CTIC's Roe CTIC's Valuation Ratios CTIC's Financial Strength Ratios CTIC's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2023, within Healthcare Sector ROI

Date modified: 2026-09-08T15:10:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.